Recurrent genital endometriosis: risk factors and possible prevention strategy

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Endometriosis is one of the most common gynecological diseases in women of reproductive age, which is characterized by a relapsing course. The recurrence rate varies greatly among literary sources. This review covers symptoms and types of endometriosis, laboratory tests, options for hormonal therapy, as well as features of surgical approaches that may be associated with the disease recurrence risk. The aim of this article was to analyze and summarize current literature on the definition of endometriosis recurrence, risk factors and prevention strategy. Despite advances in the study of various mechanisms for the development of endometriosis and the use of combined treatment, a high recurrence rate remains an unsolved problem for this disease. All of this underscores the need to develop new methods for early diagnosis and treatment, taking into account the risk group and a personalized approach.

全文:

受限制的访问

作者简介

Valeriia Semenova

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott

编辑信件的主要联系方式.
Email: pyankova.valeriia@rambler.ru
ORCID iD: 0000-0002-9101-1981
SPIN 代码: 1422-8060
Scopus 作者 ID: 57863306500
Researcher ID: HKF-5961-2023

MD, PhD student

俄罗斯联邦, Saint Petersburg

Maria Yarmolinskaya

The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott; North-Western State Medical University named after I.I. Mechnikov

Email: m.yarmolinskaya@gmail.com
ORCID iD: 0000-0002-6551-4147
SPIN 代码: 3686-3605
Scopus 作者 ID: 7801562649
Researcher ID: 2183-2014

MD, Dr. Sci. (Med.), Professor, Professor of the Russian Academy of Sciences

俄罗斯联邦, Saint Petersburg; Saint Petersburg

参考

  1. Rossiyskoe obshchestvo akusherov ginekologov (ROAG). Endometrioz. Klinicheskie rekomendatsii. 2020. (In Russ.) [cited 2023 Jan 16]. Available from: https://roag-portal.ru/recommendations_gynecology
  2. Medikamentoznaya terapiya genital’nogo endometrioza: realii i perspektivy: rukovodstvo dlya vrachey. Ed. by M.I. Yarmolinskaya. Moscow: GEOTAR-Media; 2021. (In Russ.) doi: 10.33029/9704-6034-4-MET-2021-1-384
  3. Horne A, Missmer S. Pathophysiology, diagnosis, and management of endometriosis. BMJ. 2022;379. doi: 10.1136/bmj-2022-070750
  4. Chen I, Veth VB, Choudhry AJ, et al. Pre- and postsurgical medical therapy for endometriosis surgery. Cochrane Database Syst Rev. 2020;11(11). doi: 10.1002/14651858.CD003678.pub3
  5. Sasamoto N, Ngo L, Vitonis AF, et al. Circulating proteomic profiles associated with endometriosis in adolescents and young adults. Hum Reprod. 2022;37(9):2042–2053. doi: 10.1093/humrep/deac146
  6. Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382:1244–1256. doi: 10.1056/nejmra1810764
  7. Marchandot B, Curtiaud A, Matsushita K, et al. Endometriosis and cardiovascular disease. Eur Heart J Open. 2022;2(1). doi: 10.1093/ehjopen/oeac001
  8. Ceccaroni M, Bounous VE, Clarizia R, et al. Recurrent endometriosis: a battle against an unknown enemy. Eur J Contracept Reprod Health Care. 2019;24(6):464–474. doi: 10.1080/13625187.2019.1662391
  9. Aylamazyan EK, Yarmolinskaya MI. Molotkov AS, et al. Classifications of endometriosis. Journal of Obstetrics and Women’s Diseases. 2017;66(2):77–92. (In Russ.) doi: 10.1016/10.17816/JOWD66277-92
  10. Nirgianakis K, Ma L, McKinnon B, et al. Recurrence patterns after surgery in patients with different endometriosis subtypes: a long-term hospital-based cohort study. J Clin Med. 2020;9(2):496. doi: 10.3390/jcm9020496
  11. Selçuk I., Bozdağ G. Recurrence of endometriosis; risk factors, mechanisms and biomarkers; review of the literature. J Turk Ger Gynecol Assoc. 2013;14(2):98–103. doi: 10.5152/jtgga.2013.52385
  12. Dückelmann AM, Taube E, Abesadze E, et al. When and how should peritoneal endometriosis be operated on in order to improve fertility rates and symptoms? The experience and outcomes of nearly 100 cases. Arch Gynecol Obstet. 2021;304(1):143–155. doi: 10.1007/s00404-021-05971-6
  13. Gubbels AL, Li R, Kreher D, et al. Prevalence of occult microscopic endometriosis in clinically negative peritoneum during laparoscopy for chronic pelvic pain. Int J Gynaecol Obstet. 2020;151(2):260–266. doi: 10.1002/ijgo.13303
  14. Li XY, Chao XP, Leng JH, et al. Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women. J Ovarian Res. 2019;12(1):79. doi: 10.1186/s13048-019-0552-y
  15. Lee SY, Kim ML, Seong SJ, et al. Recurrence of ovarian endometrioma in adolescents after conservative, laparoscopic cyst enucleation. J Pediatr Adolesc Gynecol. 2017;30(2):228–233. doi: 10.1016/j.jpag.2015.11.001
  16. Somigliana E, Viganò P, Benaglia L, et al. Ovarian stimulation and endometriosis progression or recurrence: a systematic review. Reprod Biomed Online. 2019;38(2):185–194. doi: 10.1016/j.rbmo.2018.11.021
  17. ESHRE Endometriosis Guideline Development Group. Endometriosis. Guideline of European Society of Human Reproduction and Embryology. 2022 [cited 2023 Jan 16]. Available from: https://www.eshre.eu/Guidelines-and-Legal/Guidelines/Endometriosis-guideline
  18. Selcuk S, Cam C, Koc N, et al. Evaluation of risk factors for the recurrence of ovarian endometriomas. Eur J Obstet Gynecol Reprod Biol. 2016;203:56–60. doi: 10.1016/j.ejogrb.2016.05.008
  19. Nezhat C, Hajhosseini B, King LP. Laparoscopic management of bowel endometriosis: predictors of severe disease and recurrence. JSLS. 2011;15(4):431–438. doi: 10.4293/108680811x13176785203752
  20. Aarestrup J, Jensen BW, Ulrich LG, et al. Birth weight, childhood body mass index and height and risks of endometriosis and adenomyosis. Ann Hum Biol. 2020;47(2):173–180. doi: 10.1080/03014460.2020.1727011
  21. Shah DK, Correia KF, Vitonis AF, et al. Body size and endometriosis: results from 20 years of follow-up within the Nurses’ Health Study II prospective cohort. Hum Reprodn. 2013;28(7):1783–1792. doi: 10.1093/humrep/det120
  22. Tobiume T, Kotani Y, Takaya H, et al. Determinant factors of postoperative recurrence of endometriosis: difference between endometrioma and pain. Eur J Obstet Gynecol Reprod Biol. 2016;205:54–59. doi: 10.1016/j.ejogrb.2016.07.516
  23. Gu Z, Li X, Shi J, et al. The development of predictive nomogram of recurrence for patients with endometrioma after cystectomy who were younger than 45 years old and received postoperative therapy. Front Med (Lausanne). 2022;9:872481. doi: 10.3389/fmed.2022.872481
  24. Yarmolinskaya MI, Semenova VO, Beganova AK. Molecular biological profile of the endometrium in patients with endometriosis (literature review). Russian Journal of Human Reproduction. 2022;28(3):54–65. (In Russ.) doi: 10.17116/repro20222803154
  25. Xu X, Chen Y, Yu Q, et al. The presence of living endometrial cells in ovarian endometriotic cyst fluid may contribute to the recurrence of endometriosis after surgical excision of endometriomas. J Ovarian Res. 2022;15(1):89. doi: 10.1186/s13048-022-01018-9
  26. Yarmolinskaya MI, Adamyan LV. Hormonal contraceptives and endometriosis: modern view on the problem. Russian Journal of Human Reproduction. 2020;26(3):39–45. (In Russ.) doi: 10.17116/repro20202603139
  27. Zakhari A, Delpero E, McKeown S, et al. Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Hum Reprod Update. 2021:27(1):96–107. doi: 10.1093/humupd/dmaa033
  28. Wattanayingcharoenchai R, Rattanasiri S, Charakorn C, et al. Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis. BJOG. 2021;128(1):25–35. doi: 10.1111/1471-0528.16366

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eсо-Vector, 2023



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.



##common.cookie##